{"filing":{"accession_number":"0001493152-26-032892","cik":"0001355736","ticker":"AVCRF","company_name":"Avricore Health Inc.","form":"6-K","filing_date":"2026-07-10","report_date":null,"primary_document":"form6-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1355736/000149315226032892/form6-k.htm"},"events":[{"id":17451,"run_id":15625,"accession_number":"0001493152-26-032892","anchor_item_number":"EX-99.6","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"This exhibit is Form 45-106F1, a Canadian \"Report of Exempt Distribution\" template used to disclose private placements and exempt offerings of securities. The form's structure and instructions indicate it is filed to report distributions of securities (shares, notes, warrants, etc.) made under exemptions from prospectus requirements in Canadian securities law. While the exhibit shown is the blank form template rather than a completed report with specific transaction details, its presence as an exhibit to a 6-K filing by Avricore Health indicates the company has conducted or is reporting an exempt distribution—a dilutive issuance of equity or debt securities outside registered public offerings. This is material to investors as it affects share dilution and capital structure.","company_name":"Avricore Health Inc.","ticker":"AVCRF","filing_date":"2026-07-10","form":"6-K","submitted_at":null,"items":[{"id":15927,"accession_number":"0001493152-26-032892","item_number":"EX-99.6","item_title":"ex6.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This exhibit is Form 45-106F1, a Canadian \"Report of Exempt Distribution\" template used to disclose private placements and exempt offerings of securities. The form's structure and instructions indicate it is filed to report distributions of securities (shares, notes, warrants, etc.) made under exemptions from prospectus requirements in Canadian securities law. While the exhibit shown is the blank form template rather than a completed report with specific transaction details, its presence as an exhibit to a 6-K filing by Avricore Health indicates the company has conducted or is reporting an exempt distribution—a dilutive issuance of equity or debt securities outside registered public offerings. This is material to investors as it affects share dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T11:10:15.794187+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":15927,"accession_number":"0001493152-26-032892","item_number":"EX-99.6","item_title":"ex6.htm","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"reasoning":"This exhibit is Form 45-106F1, a Canadian \"Report of Exempt Distribution\" template used to disclose private placements and exempt offerings of securities. The form's structure and instructions indicate it is filed to report distributions of securities (shares, notes, warrants, etc.) made under exemptions from prospectus requirements in Canadian securities law. While the exhibit shown is the blank form template rather than a completed report with specific transaction details, its presence as an exhibit to a 6-K filing by Avricore Health indicates the company has conducted or is reporting an exempt distribution—a dilutive issuance of equity or debt securities outside registered public offerings. This is material to investors as it affects share dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-13T11:10:15.794187+00:00","company_name":"Avricore Health Inc.","ticker":"AVCRF","filing_date":"2026-07-10"}]}